Ernst & Young’s (EY) annual Pulse of the Industry report offers plenty of reasons for optimism within med tech as the impact of the pandemic recedes, while identifying several key areas that will require continued focus for the sector’s long-term success. Read More
Medtronic plc has launched Medtronic Neurovascular Co-Lab platform, a major initiative to speed the pace of innovations in stroke treatment and access for patients around the world. The neurovascular innovation incubator will bring together innovators, entrepreneurs and physicians to collaborate and share their ideas about promising products and solutions. Read More
The U.S. FDA’s interest in regulating lab-developed tests (LDTs) occasionally prompts the agency to engage in a little saber-rattling about rulemaking if Congress should fail to pass legislation granting the FDA explicit authority to regulate these tests.
The new EU Medical Devices Regulation (MDR) is not going down well with Swiss medical technology manufacturers. At a conference held on Oct. 19 in Bern, Switzerland on introducing the new EU MDR, the Swiss medical technology association, Swiss Medtech, which represents more than 700 firms, put out a harsh and definitive statement. Read More
The U.K. is launching a £230 million (US$260 million) project to build a database linking the health records and genetic information of 5 million people, which will be open for discovery research and as a source of clinical trial recruits for academics and companies. Read More
New hires and promotions in the med-tech industry, including: Biostem, Encare, Intervenn Bioscience, Predictive Oncology, Surgimate, Trinity Biotech. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biocorp, Biosig, Cardio Diagnostics, Enspectra, Gentegra, HTG, Novo Nordisk, Omnicure, Opsens, Thorne. Read More
